These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24788801)

  • 21. Artesunate- and amodiaquine-associated extrapyramidal reactions: a series of 49 cases in VigiBase™.
    McEwen J
    Drug Saf; 2012 Aug; 35(8):667-75. PubMed ID: 22788236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy follow-up: Role in active malaria surveillance in a travel medicine centre outside the transmission area in Brazil.
    Pedro RS; Brasil P; Pina-Costa A; Machado CR; Damasceno LS; Daniel-Ribeiro CT; Guaraldo L
    J Clin Pharm Ther; 2017 Dec; 42(6):750-757. PubMed ID: 28612497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The WHO 'Roll Back Malaria Project': planning for adverse event monitoring in Africa.
    Simooya O
    Drug Saf; 2005; 28(4):277-86. PubMed ID: 15783238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malaria Surveillance - United States, 2017.
    Mace KE; Lucchi NW; Tan KR
    MMWR Surveill Summ; 2021 Mar; 70(2):1-35. PubMed ID: 33735166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.
    Kabanywanyi AM; Mulure N; Migoha C; Malila A; Lengeler C; Schlienger R; Genton B
    Malar J; 2010 Jul; 9():205. PubMed ID: 20630066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda.
    Rulisa S; Kaligirwa N; Agaba S; Karema C; Mens PF; de Vries PJ
    Malar J; 2012 Jul; 11():225. PubMed ID: 22770264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescriber practices and patient adherence to artemisinin-based combination therapy for the treatment of uncomplicated malaria in Guinea, 2016.
    Camara A; Moriarty LF; Guilavogui T; Diakité PS; Zoumanigui JS; Sidibé S; Bah I; Kaba I; Kourouma D; Zoumanigui K; Plucinski M
    Malar J; 2019 Jan; 18(1):23. PubMed ID: 30683128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.
    Mendes D; Rigueiro G; Silva RS; Penedones A; Alves C; Sousa G; Batel-Marques F
    J Oncol Pharm Pract; 2020 Jan; 26(1):133-140. PubMed ID: 31117914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing adverse events reporting within the health care system: the case of artemisinin-based combination treatments in northern Ghana.
    Chatio S; Aborigo R; Adongo PB; Anyorigiya T; Dalinjong PA; Akweongo P; Oduro A
    Malar J; 2016 Feb; 15():125. PubMed ID: 26921239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
    Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
    Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacovigilance of antimalarial treatment in Africa: is it possible?
    Talisuna AO; Staedke SG; D'Alessandro U
    Malar J; 2006 Jun; 5():50. PubMed ID: 16780575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.
    Sabblah GT; Darko DM; Mogtari H; Härmark L; van Puijenbroek E
    Drug Saf; 2017 Oct; 40(10):911-921. PubMed ID: 28653291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
    Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
    Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda.
    Ampadu HH; Asante KP; Bosomprah S; Akakpo S; Hugo P; Gardarsdottir H; Leufkens HGM; Kajungu D; Dodoo ANO
    Malar J; 2019 Feb; 18(1):36. PubMed ID: 30736864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring.
    Kuemmerle A; Dodoo AN; Olsson S; Van Erps J; Burri C; Lalvani PS
    Malar J; 2011 Mar; 10():57. PubMed ID: 21388536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis.
    Rolling T; Wichmann D; Schmiedel S; Burchard GD; Kluge S; Cramer JP
    Malar J; 2013 Jul; 12():241. PubMed ID: 23855745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    ACCESS-SMC Partnership
    Lancet; 2020 Dec; 396(10265):1829-1840. PubMed ID: 33278936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural Tanzania.
    Njau JD; Kabanywanyi AM; Goodman CA; Macarthur JR; Kapella BK; Gimnig JE; Kahigwa E; Bloland PB; Abdulla SM; Kachur SP
    Malar J; 2013 Jul; 12():236. PubMed ID: 23844934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.
    Kunac DL; Tatley MV
    Drug Saf; 2011 Jan; 34(1):59-71. PubMed ID: 21142271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.